Analysts at Macquarie upgraded shares of First Financial Bankshares Inc (NASDAQ:FFIN)from an “underperform” rating to a “neutral” rating in a research note on Friday, May 16th. First Financial Bankshares Inc (NASDAQ:FFIN) net profit margin is 44.60% and weekly performance is 0.03%. On last trading day company shares ended up $30.20. Analysts mean target price for the company is $58.86. First Financial Bankshares Inc (NASDAQ:FFIN) distance from 50-day simple moving average (SMA50) is 1.03%.
Quiksilver Inc. (NYSE:ZQK) saw a big move last session, as the company’s shares fell by over 41% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for ZQK, as the stock is now down almost 50% in the past one-month time frame. Quiksilver, Inc. (NYSE:ZQK) shares fell -41.11% in last trading session and ended the day on $3.41. Gross Margin is 48.10% and its return on assets is -10.50%. Quiksilver, Inc. (NYSE:ZQK) quarterly performance is -56.73%.
The Ensign Group, Inc. (NASDAQ:ENSG) the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services, home health, hospice care, assisted living and urgent care companies, announced the successful completion of its spin-off of CareTrust REIT, Inc. In the spin-off, Ensign stockholders received one share of CareTrust common stock for each share of Ensign common stock held at the close of business on May 22, 2014. The spin-off is effective from and after June 1, 2014, with CareTrust shares distributed on June 2, 2014. The Ensign Group, Inc. (NASDAQ:ENSG) shares moved up 13.88% in last trading session and was closed at $29.53, while trading in range of $26.02- $29.84. The Ensign Group, Inc. (NASDAQ:ENSG) year to date (YTD) performance is 22.48%.
O May 21, Equities researchers at Telsey Advisory Group decreased their price target on shares of ROI Acquisition Corp (NASDAQ:EVRY) from $6.00 to $3.00 in a research report issued on Monday. The firm currently has a “not rated” rating on the stock. Telsey Advisory Group’s target price would suggest a potential upside of 194.12% from the company’s current price. ROI Acquisition Corp (NASDAQ:EVRY) ended the last trading day at $1.36. Company weekly volatility is calculated as 50.76% and price to cash ratio as 9.39. ROI Acquisition Corp (NASDAQ:EVRY) showed a positive weekly performance of 37.37%.
Clovis Oncology Inc. (NASDAQ:CLVS) presented results of its Phase 1 and early Phase 2 portions of its ongoing Phase 1/2 clinical study of CO-1686 at ASCO over the weekend. The results raised concerns over the risks the lung cancer treatment could potentially have, namely concerns over diabetes. Clovis Oncology Inc (NASDAQ:CLVS) weekly performance is -26.17%. On last trading day company shares ended up $38.23. Analysts mean target price for the company is $98.63. Clovis Oncology Inc (NASDAQ:CLVS) distance from 50-day simple moving average (SMA50) is -34.71%.